Tracking inclusion of women in clinical studies

Journal of Women's Health

Volumn 18, Issue 3, 2009, Pages 301-302

  Wood, Susan F ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL STUDY; DEMOGRAPHY; DRUG APPROVAL; DRUG LABELING; EDITORIAL; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL INFORMATION; PRIORITY JOURNAL; SEX DIFFERENCE; WOMEN'S HEALTH;

ADULT; AGE DISTRIBUTION; AGED; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMAN EXPERIMENTATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; SEX DISTRIBUTION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WOMEN'S HEALTH;

EID: 62449158213     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1308     Document Type: Editorial

References (4)

1. Food and Drug Administration. Study and evaluation of gender differences in the clinical evaluation of drugs. 1993. Available at www.fda.gov/guidance/ old036fn.pdf
2. Yang Y, Carlin AS, Faustino PJ, et al. Participation of woman in clinical trials for new drugs approved by the Food and Drug Administration in 2000-2002. J Women's Health 2009; 18: xxx-xxx.
3. Evelyn B, Toigo T, Banks D, et al. Women's participation in clinical trials and sex-related labeling: A review of new molecular entities approved 1995-1999. Available at www.fda.gov/cder/reports/womens-health/women-clin- trials.htm
4. Uhl K, Parekh A, Kweder S. Females in clinical studies: Where are we going? Clin Pharmacol Ther 2007;81:600-602.